VTVT Chart
- 52-Week Range: $9.02 - $40.40
- Market Capitalization: $23.43M
- Short Percentage: 0%
- Target Price: $2.00
- Shares Outstanding: 2.04M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
VTVT released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- vTv Therapeutics Announces 2023 Second Quarter Financial Results and Provides Corporate UpdateGlobeNewsWire | August 11th
- 3 Pharma Stocks That Could Benefit from Global Healthcare TrendsInvestorPlace | March 17th
- Elizabeth Keiley Selected as Executive Vice President and General Counsel of vTv TherapeuticsGlobeNewsWire | February 1st
- vTv Therapeutics Appoints Biotech Industry Veteran Steven Tuch as Chief Financial OfficerGlobeNewsWire | December 13th
- vTv Therapeutics Announces 2022 Third Quarter Financial Results and Provides Corporate UpdateGlobeNewsWire | November 10th
Company Info
Website: https://www.vtvtherapeutics.com
Address: 3980 Premier Drive, High Point, NC, United States, 27265
Sector: Healthcare
Industry: Biotechnology
Full time employees: 13
Address: 3980 Premier Drive, High Point, NC, United States, 27265
Sector: Healthcare
Industry: Biotechnology
Full time employees: 13
$VTVT trash
$VTVT has just been halted from trading.
$VTVT Who’s still buying calls?
$VTVT I can wait.
$VTVT warming up
$VTVT low volume today isn’t necessarily a bad thing
$VTVT just bought a half position.
$VTVT wtf is that dump
$VTVT Like if the Hedgies are fucked
$VTVT Going up